Next Article in Journal
Combined Use of Deep Eutectic Solvents, Macroporous Resins, and Preparative Liquid Chromatography for the Isolation and Purification of Flavonoids and 20-Hydroxyecdysone from Chenopodium quinoa Willd
Next Article in Special Issue
New Insights into the Control of Cell Fate Choices and Differentiation by Retinoic Acid in Cranial, Axial and Caudal Structures
Previous Article in Journal
Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate Induces Cell Death with Coexisting Mitotic Arrest and Autophagy in Human Chronic Myelogenous Leukemia K562 Cells
Previous Article in Special Issue
Retinol Saturase Knock-Out Mice are Characterized by Impaired Clearance of Apoptotic Cells and Develop Mild Autoimmunity
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Retinoic Acid and Germ Cell Development in the Ovary and Testis

Immunology Frontier Research Center, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita 565-0871, Japan
Whitehead Institute, Cambridge, MA 02142, USA
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Howard Hughes Medical Institute, Whitehead Institute, Cambridge, MA 02142, USA
Reproductive Biology Group, Division of Developmental Biology, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands
Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomolecules 2019, 9(12), 775;
Submission received: 31 October 2019 / Revised: 22 November 2019 / Accepted: 23 November 2019 / Published: 24 November 2019
(This article belongs to the Special Issue Retinoids in Embryonic Development)


Retinoic acid (RA), a derivative of vitamin A, is critical for the production of oocytes and sperm in mammals. These gametes derive from primordial germ cells, which colonize the nascent gonad, and later undertake sexual differentiation to produce oocytes or sperm. During fetal development, germ cells in the ovary initiate meiosis in response to RA, whereas those in the testis do not yet initiate meiosis, as they are insulated from RA, and undergo cell cycle arrest. After birth, male germ cells resume proliferation and undergo a transition to spermatogonia, which are destined to develop into haploid spermatozoa via spermatogenesis. Recent findings indicate that RA levels change periodically in adult testes to direct not only meiotic initiation, but also other key developmental transitions to ensure that spermatogenesis is precisely organized for the prodigious output of sperm. This review focuses on how female and male germ cells develop in the ovary and testis, respectively, and the role of RA in this process.

1. Introduction

Mammalian oocytes and sperm derive from the same embryonic precursor cells, called primordial germ cells (PGCs). In development, PGCs migrate to the somatic gonad, where they undertake gametogenesis to ultimately produce oocytes or sperm, depending on whether they are in an ovary (female) or a testis (male). In mice, differences between the somatic cellular composition of ovaries and testes are microscopically evident by embryonic day (E) 12.5 [1,2,3]. Germ cells, however, remain morphologically indistinguishable between the sexes until E13.5 [4,5]. Subsequently, female germ cells enter meiotic prophase I and begin to differentiate as oocytes, whereas male germ cells remain mitotically active, and later arrest in the G0/G1 phase of the mitotic cell cycle [4,5].
In the 1970s, Byskov and Saxen [6] suggested that a “meiosis inducing substance”, present in the embryonic ovary, is required for germ cells to initiate meiotic prophase. Recent studies find that retinoic acid (RA) is such a meiosis-inducing substance, produced by the somatic cells of the gonad and mesonephros [7,8,9]. RA is generated from dietary vitamin A (also known as retinol) by a series of oxidative reactions. Local levels of RA are regulated by retinaldehyde dehydrogenases, which catalyze the last step of RA synthesis, and by a cytochrome p450 enzyme (CYP26B1), which degrades RA [10,11] (reviewed in [12,13]). This metabolism of RA regulates whether female and male germ cells initiate meiosis in the fetal ovary, or the adult testis, respectively.
Male germ cells, which are arrested in G0/G1 phase of the cell cycle in the fetal testis, later resume proliferation and undergo a transition to spermatogonia after birth [14,15]. Spermatogonia, which include germline stem cells, undergo an elaborately organized process to give rise to specialized haploid gametes, called spermatozoa [16]. The complete process of germ cell development, from spermatogonia to spermatozoa, is called spermatogenesis. Within the testis, several developmental transitions of spermatogenesis, including spermatogonial differentiation and meiotic initiation, occur in close physical and temporal proximity. Over several decades, pharmacological and genetic studies have revealed that these key transitions are strictly regulated by RA [17,18,19]. In this review, we focus on how germ cell development is coordinated in the ovary and testis, and the instructive role of RA in this process.

2. Germ Cell Development in the Fetal Gonad

Shortly after entry to the gonads, germ cells acquire the competence for meiotic initiation and sexual differentiation in the fetal gonad. Whether germ cells initiate meiosis or continue in a mitotic cell cycle is determined by their gonadal environment, rather than their sex chromosome constitution (reviewed in [20]). Germ cells in the fetal ovary are exposed to RA and initiate meiosis, whereas those in the fetal testis are sequestered from RA signaling and do not initiate meiosis until after birth.

2.1. Formation of the Gonad and Migration of PGCs to the Gonad

In mammals, both the ovary and testis derive from a common precursor structure, the bipotential gonad (Figure 1) [21]. The development of the bipotential gonad involves two simultaneously occurring processes. The coelomic epithelium develops into a thickened, multilayer structure, known as the genital ridge. This differentiation initiates at the coelomic epithelium’s anterior end and extends posteriorly [3,21]. In mice, the development of the bipotential gonad begins at around E10.0 and continues until E11.5–E12.0 [1,2,3]. Thereafter, the gonad’s somatic cells undergo sexual differentiation [1,2,3].
Meanwhile, PGCs, the precursors of sperm and eggs, are induced early in embryogenesis, and later migrate to the developing genital ridge [22]. Throughout their migration, PGCs maintain a transcriptional program of developmentally uncommitted cells, marked by the expression of both naïve and general pluripotency factors [24,25,26]. Upon colonization of the nascent gonad, human and mouse PGCs induce a set of germ cell factors, including evolutionarily conserved markers of germ granules [24]. After their arrival in the gonad, PGCs subsequently down-regulate the expression of pluripotency factors, and lose the capacity to give rise to pluripotent cell lines (known an embryonic germ [EG] cells) and teratomas, a tumor arising from pluripotent cells [24,27,28]. This transition, broadly conserved among vertebrates, serves to restrict the developmental potential of the mammalian germ line, a process termed germ cell determination [24].

2.2. Initiation of Gametogenesis and Meiotic Entry

Once determined, germ cells are poised to initiate meiosis, as well as undertake male or female differentiation [29,30]. The transition of PGCs to committed germ cells represents a critical transformation of the germ line to a sexually competent state [31], and is induced by extrinsic signals from the genital ridge [32]. One of the genes induced at PGC colonization in mice and humans is Dazl [24], which encodes an evolutionarily conserved and germ-cell-specific RNA-binding protein (Figure 2) [33]. In Dazl-null mouse embryos, PGCs arrive at the gonad, but fail to restrict their developmental potential; instead, these cells remain proliferative, continue to express pluripotency factors, retain the capacity for the derivation of pluripotent EG cells until at least E15.5, and fail to initiate meiosis or embark upon spermatogenesis or oogenesis in the fetal testis or ovary, respectively [24,31,34,35]. Consistent with the failure to restrict germline potential, Dazl-deficient mice and pigs develop spontaneous teratomas at an elevated frequency [24]. Thus, Dazl is necessary for the germ line to undertake a restriction of potential, and for the competence to undertake gametogenesis, defined as the capacity to initiate meiosis and sexual differentiation [31].
On expression of DAZL, germ cells acquire the competence to interpret RA as a meiosis-inducing signal (Figure 2) [7,8,35]. RA induces germ cells to express both Stra8 (Stimulated by Retinoic acid gene 8), a gene required for meiotic initiation [36], and Rec8, a gene required for meiotic progression [37,38] (Figure 1 and Figure 2) [39,40]. These two factors are independently activated by RA (Figure 2) [39,41] and precede the expression of other meiotic markers, such as Dmc1, Sycp3, and the phosphorylation of histone H2AX (γH2AX), which is a marker of meiotic double strand breaks [26,40,42,43].
Like the preceding differentiation of the somatic cells, many aspects of germline development occur in an anterior-to-posterior (A-P) wave along the length of the gonad [26,32,40,42,44]. At E11.5, newly arrived PGCs show a gradient of Dazl expression, which is highest in the anterior portion of the gonad and low or absent in the posterior portion (Figure 1) [32].

2.3. Stra8 and Its Inducer, RA, Regulate Meiotic Initiation in the Fetal Ovary

Stra8 is highly expressed in germ cells of both sexes at meiotic initiation, before quickly turning off early in meiosis [18,36,40]. Stra8 expression in ovarian germ cells begins at E12.5 and progresses in a subsequent A-P wave, such that the expression of Stra8 and other meiotic markers is heterogeneous across the population of germ cells (Figure 1) [26,39,40]. In the fetal ovary, Stra8 is first detected within one day prior to when the characteristically condensed chromatin of meiotic germ cells can be observed (Figure 1 and Figure 2) [40]. In mice of the C57BL/6 genetic background, Stra8-null ovarian germ cells do not undergo meiotic DNA replication [36], nor do they robustly express meiotic factors or begin the chromosomal events of meiotic prophase I [36,41]; thus, Stra8 is necessary for meiotic initiation in mice. STRA8 is a transcriptional activator that binds to the promoters and enhances the expression of thousands of genes, including meiotic prophase I genes, G1-S cell-cycle genes, and factors that specifically inhibit the mitotic program [45]. In fetal testes, male germ cells do not express Stra8 (Figure 1 and Figure 2) [40]. Instead, Stra8 is first expressed much later in germ cells of postnatal testes, when they undergo differentiation [46,47,48].
A potential link between RA and meiotic initiation was initially provided by in vivo studies of the Stra8 gene [36,40], which was first identified as an RA-inducible gene in embryonal carcinoma cells and embryonic stem cells in vitro [46]. In fetal ovaries, all-trans RA robustly induces Stra8 expression and thereby meiotic initiation (Figure 2) [7,8]. Exogenous all-trans RA is sufficient to induce ectopic Stra8 expression, and for the precocious initiation of meiosis in fetal testes [7,8]. Later work provided direct evidence for RA’s role in meiotic initiation—in the ovaries of vitamin A-deficient rat embryos, Stra8 is not robustly activated, and germ cells fail to enter meiosis [49]. Thus, RA can induce meiotic initiation in both female and male germ cells of the fetal gonad.
Two families of nuclear hormone receptors, known as RA receptors (RARs) and retinoid X receptors (RXRs), bind RA. RARs bind both all-trans and 9-cis RA stereoisoforms, while RXRs bind only 9-cis RA [50]. RXRs can also bind other ligands that are not derived from RA [51] (reviewed in [52,53]), but it is unclear whether these ligands contribute to meiotic initiation. RARs and RXRs interact to form heterodimers that bind to RA response elements (RAREs) in the regulatory regions of target genes [54]. RXRs can also heterodimerize with other nuclear hormone receptors (reviewed in [55]), but whether these interactions promote meiotic initiation is not yet known. RARs and RXRs each have three isotypes (RARα, RARβ, and RARγ, and RXRα, RXRβ, and RXRγ), and each exhibits overlapping expression and functional redundancy in many tissues (reviewed in [54,56,57]). Both RAR and RXR isotypes are expressed in the gonads of each sex [8,58,59,60,61]. In embryonic ovaries, RARs are readily detected in germ cells but are expressed at very low levels, if at all, in somatic cells [8,58,62], while RXRs are found in both somatic and germ cells [8,62]. The promoter of the Stra8 gene contains two putative RAREs, suggesting that RA may directly up-regulate Stra8 transcription by binding to RAR/RXR heterodimers engaged at the Stra8 promoter [46,63]. Indeed, antagonists of the RARs diminish or block Stra8 expression, while exogenous RA induces Stra8 expression in the fetal ovary [7,8].

2.4. Source of RA in the Fetal Ovary

RA originating from both the somatic cells of the fetal ovary and mesonephros likely contribute to meiotic initiation (Figure 2) [8,9]. Initial studies identified the mesonephros as a robust source of RA, as these cells strongly expressed a lacZ reporter transgene under the control of an RARE [8]. Weaker RARE-lacZ signal was detected in the fetal gonad, with the strongest gonadal signal detected at the anterior end [8]. The mesonephros expresses two RA-synthesizing enzymes (Figure 2), aldehyde dehydrogenase 1A2 (Aldh1a2) [8] and Aldh1a3 [64]. Upon deletion of Aldh1a2 or both Aldh1a2 and Aldh1a3, the mesonephros fails to produce RA, as evidenced by the loss of RARE-lacZ signal in transgenic mice [65]. At the same time, the ovarian germ cells from these mutant embryos express Stra8 and initiate meiosis [65]. Therefore, mesonephros-derived RA is not strictly required for meiotic initiation.
Based on these findings, some have proposed that RA itself is not required for meiotic initiation in the ovary [65]. However, subsequent work demonstrated that germ cells from cultured fetal ovaries initiate meiosis in the absence of the mesonephros, suggesting that an alternative source of RA—such as the fetal ovary—is sufficient for meiotic initiation [66]. Additional studies indicated that the somatic cells of the fetal gonad express Aldh1a1 and therefore produce RA (Figure 2) [9,66,67]. Further, genetic deletion of Aldh1a1 decreases RA levels in the fetal ovary [9]. While Aldh1a1-deficient fetal ovaries initially exhibit reduced expression of Stra8 and other genes that are usually upregulated at meiotic initiation, these meiotic factors are expressed at similar levels one day later, suggesting that RA derived from the mesonephros allows the germ cells to initiate meiosis and overcome the earlier delay [9]. Consistent with this recovery, Aldh1a1-null female mice are fertile [68]. Therefore, RA derived from the fetal ovary via Aldh1a1 regulates the timing of meiotic initiation, but is not strictly required. At the same time, Aldh1a1 provides sufficient RA to initiate meiosis in the ovaries of Aldh1a2-null; Aldh1a3-null embryos.
That Aldh1a1 is redundant for meiotic initiation may be accounted for by its inverse expression in response to RA levels. In fetal testes lacking Cyp26b1, endogenous RA levels are elevated, and Aldh1a1 expression is greatly reduced, suggesting a negative feedback loop between RA signaling and Aldh1a1 expression [9]. Therefore, the elimination of mesonephros-derived RA by deletion of Aldh1a2 and Aldh1a3 may cause an increase in Aldh1a1 expression in the gonad, raising RA levels in the fetal ovary [9]. In the embryonic ovary, RA produced by both the mesonephros and somatic gonad likely contributes to meiotic initiation.
Early studies of RA activity proposed that RA diffuses through the fetal gonad in an A-P manner to produce an A-P wave of meiotic initiation (Figure 1 and Figure 2) (reviewed in [69,70]). While the mesonephros is attached to the gonad along its dorsal length, only the anterior mesonephric tubules are open and directly connected to the gonad (Figure 1) [71,72]. Thus, RA may diffuse from the mesonephros into the gonad via this anterior connection [8] (reviewed in [69]). Alternatively, some RA-producing cells may migrate from the anterior mesonephros into the anterior gonad (reviewed in [69]). Both scenarios could establish an A-P gradient that drives the observed wave of meiotic initiation. Consistent with this model, the RARE-lacZ reporter is detected in the fetal ovary in an A-P manner [8,9].
An A-P wave of Dazl expression precedes, and may also contribute to, the subsequent wave of meiotic initiation (Figure 1) [32]. On Dazl expression, germ cells acquire the ability to interpret RA as a meiosis-inducing factor [35] in an A-P manner (Figure 1) [32]. This wave of intrinsic germ cell competence may reinforce an RA gradient in inducing meiosis along the gonad. Alternatively, the A-P wave of intrinsic germ cell competence may drive the subsequent wave of meiotic initiation, independent of any differences in the local concentration of RA along the length of the gonad. Regardless, RA can induce Dazl expression in cultured PGC-like cells [73], which suggests an additional instructive role for RA in the development of germ cells in both the XX and XY-bearing cells, days prior to meiotic initiation.

2.5. Prevention of Meiotic Initiation in the Fetal Testis

In fetal testes, CYP26B1 degrades RA, thereby precluding the induction of Stra8, and preventing the initiation of meiosis (Figure 2) [7,8]. Cyp26b1 is expressed in somatic cells of the developing testis (seminiferous) cords [7,8,74,75]. In Cyp26b1-deficient embryos, germ cells in the fetal testis express ectopic Stra8 and initiate meiosis [8,76]. Thus, CYP26B1-expressing cells form a catabolic barrier that prevents RA, generated outside of the cords, from reaching the germ cells located within. The expression level of Cyp26b1 in mouse fetal testes is maintained until E13.5, and reduced gradually thereafter [77]. The subsequent reduction of Cyp26b1 may expose male germ cells to some RA, but male germ cells avoid a direct response, in part, through Nanos2, which prevents meiotic initiation in the fetal testis [77,78,79] (reviewed in [70,80,81]). The expression of Nanos2, which encodes a germ cell-specific RNA binding protein [82], is up-regulated from E13.5 onward and is restricted to the male germline [77,83]. In Nanos2-null embryos, male germ cells express low levels of Stra8 and initiate ectopic meiosis at E14.5 [77], indicating that Nanos2 operates subsequent to RA catabolism by Cyp26b1 to prevent cells from initiating meiosis. The authors also reported that Nanos2 inhibits meiosis, in part, by destabilizing Dazl and other down-stream targets (Figure 2) [79]. Thus, Nanos2 is a cell-intrinsic factor that prevents the male germline from interpreting RA as a meiosis-inducing factor.

2.6. A Role for RA in the Ovary after Birth

After meiotic initiation, ovarian germ cells enter an extended meiotic prophase I, and begin differentiation as oocytes [36]. In mice, oocytes that progress through meiotic prophase I will arrest at the diplotene stage, also known as dictyate or germinal vesicle (GV) stage, around birth (reviewed in [84,85,86]). Shortly after birth, oocytes grow and differentiate independent of the chromosomal events of meiosis [87]. Meanwhile, oocytes organize the supporting somatic cells, called granulosa cells, to form follicles [88], which later undertake ovulation in response to hormonal stimulation. During and after puberty, groups of follicles will grow in size through both granulosa cell proliferation and the growth of the oocyte, which remain arrested at the GV stage (reviewed in [86]). Around the time of ovulation, full-grown GV stage oocytes resume meiosis, break down the nuclear envelope (GV breakdown), undergo meiotic progression, and arrest again at meiotic metaphase II (MII) until fertilization; the process from GV to MII stage is referred to as oocyte maturation, which is promoted by granulosa cells (reviewed in [84,85]).
Recent in vitro studies have proposed that both all-trans and 9-cis RA can act on granulosa cells to improve oocyte maturation in several mammals, including cows [89,90,91,92,93], goats [94], pigs [95], rats [96], and mice [97,98] (reviewed in [99,100]). RARs and RXRs are expressed in granulosa cells surrounding full-grown oocytes [96,101,102]. Supplementation of culture medium with all-trans or 9-cis RA induces granulosa cells to express genes that regulate differentiation and prevent apoptosis [90,92,93,94,103,104] (reviewed in [99]), suggesting that RA acts on granulosa cells to prevent their aberrant differentiation state and apoptosis. In vivo, RARE-lacZ signal is detected in granulosa cells of mouse ovarian follicles at 3 weeks of age, and increased after injection of a gonadotropic hormone [102], supporting a role for RA on these cells. Further in vivo studies are needed to determine whether RA is required by granulosa cells to support oocyte maturation in the ovary.

3. Development of Male Germ Cells after Birth

After birth, male germ cells differentiate into spermatogonia and initiate spermatogenesis, a process in which spermatogonial stem cells ultimately give rise to millions of haploid spermatozoa per day. Throughout spermatogenesis, several transitions occur in a strictly coordinated manner, including meiotic initiation, which is induced by periodic RA signaling, ensuring that spermatozoa are produced at a constant rate throughout reproductive life in males.

3.1. Organization of Spermatogenesis in the Postnatal and Adult Testis

In the fetal mouse testis, PGCs are enclosed by somatic cells as testis cords are formed between E12.5 to E14.0 (Figure 1) [14,23]. The germ cells present within the testis cords differ morphologically from migratory PGCs, and are called gonocytes [14,15]. Shortly after birth, the gonocytes, which are arrested in the G0/G1 phase [4,5], resume proliferation and migrate to the basement of the cords to give rise to type A spermatogonia (Figure 3) [14,15,105].
In mice, spermatogenesis begins with undifferentiated type A spermatogonia, which include the stem cells [107,108,109,110] (reviewed in [111]). Individual spermatogonial cells, known as A single (As) spermatogonia, have traditionally been considered to encompass spermatogonial stem cells (Figure 4) [107,108,112]. Some of the As spermatogonia divide into paired A (Apr) spermatogonia, which are connected by an intercellular bridges. The Apr spermatogonia subsequently divide further into extended chains of 4, 8, or 16 cells, called Aaligned (Aal) spermatogonia. As, Apr, and Aal spermatogonia are referred to as undifferentiated spermatogonia (Figure 4) (reviewed in [113]).
Undifferentiated spermatogonia periodically commit to differentiation, in the form of an Aal-to-A1 transition, to become differentiating spermatogonia, which encompass A1, A2, A3, A4, intermediate and B spermatogonia (Figure 4 and Figure 5) (reviewed in [114,115]). During differentiation, spermatogonia lose the capacity for self-renewal [116], accelerate their cell cycle [117], and undertake six mitotic divisions in mice [118]. Germ cells then differentiate to spermatocytes and undergo meiotic initiation (Figure 5) [18,36]. DNA replication and two cell divisions follow, resulting in the formation of haploid, round spermatids, which elongate their nucleus and cytoplasm to become elongated spermatids. Finally, these spermatids are released into the lumen of the seminiferous epithelium, whereupon they are referred to as spermatozoa (Figure 3 and Figure 5) (reviewed in [119]). These layered generations of germ cells are embedded in and supported by somatic Sertoli cells that supply factors essential for spermatogenesis (Figure 3) (reviewed in [120,121]).
Within cross-sections of the seminiferous epithelium, stereotypical collections or associations of germ cells occur at various steps of differentiation (Figure 3 and Figure 5). The precise coordination of these steps is called the “cycle of the seminiferous epithelium” (or “seminiferous cycle”). In mice, the seminiferous cycle has been subdivided into 12 distinct cellular associations, known as seminiferous (epithelial) stages I to XII [106]. During spermatogenesis, four transitions direct key phases of germ cell development: (i) differentiation of spermatogonia, (ii) meiotic initiation, (iii) initiation of spermatid elongation, and (iv) the release of elongated spermatids into the lumen of seminiferous tubules (spermiation) (Figure 5). These four transitions are precisely coordinated in time and space, each occurring in stages VII and VIII of the seminiferous epithelium (Figure 5) [106] (reviewed in [16,111]). The close physical and temporal proximity of each of these transitions, occurring cyclically, with an 8.6-d periodicity in mice [122], suggests a strict coordination. The intimate proximity of each of these transitions is largely conserved in other mammals, including humans [125], rats [112,126], hamsters [127], and rams [127].

3.2. Regulation of Spermatogenesis by Vitamin A and RA

A central role for RA in mammalian spermatogenesis was first described in 1925, when rodents fed a vitamin A-deficient (VAD) diet were found to be sterile [128,129,130] (reviewed in [131,132]). In VAD mice and rats, most germ cells arrest as undifferentiated spermatogonia [133,134,135,136,137]. In VAD rat testes, some germ cells arrest just prior to meiosis, as preleptotene spermatocytes [17,136,138]. When VAD animals are given an injection of all-trans RA, or vitamin A, the arrested spermatogonia undertake differentiation [17,135,137], and the arrested preleptotene spermatocytes initiate meiosis [17]. Further, mice treated daily with WIN18,446—which inhibits the retinaldehyde dehydrogenases (ALDH1A1-3) and thereby prevents local RA production [139,140]—exhibited blocks in both spermatogonial differentiation and meiotic initiation [124,141,142]. Thus, in males, both these premeiotic transitions—spermatogonial differentiation and meiotic initiation—require RA.

3.3. The Role of RA and Stra8 at Spermatogonial Differentiation and Meiotic Initiation

Stra8, which is required for meiotic initiation, also promotes (but is not strictly required for) spermatogonial differentiation [124]. In the postnatal mouse testis, the STRA8 protein is detected in spermatogonia as early as postnatal day 2 (P2) [47,143], when the first evidence of spermatogonial differentiation occurs [144]. In the adult testis, STRA8 is expressed at spermatogonial differentiation of Aal spermatogonia, and in preleptotene spermatocytes at meiotic initiation; both occur during stages VII–VIII (Figure 4 and Figure 5) [124,145,146]. In mice lacking Stra8, undifferentiated spermatogonia accumulate in unusually high numbers as early as P10 [124], and the remaining germ cells arrest just prior to meiosis, as preleptotene spermatocytes [18,36]. Thus, RA acts instructively, and at least in part through STRA8, at spermatogonial differentiation, distinct from its critical function in meiotic initiation [124].
Unlike RA deficiency, genetic ablation of Stra8 does not preclude spermatogonial differentiation [124], indicating that RA has additional effects, aside from inducing Stra8 expression, at this transition. Culture experiments [48,147] indicate that treatment of undifferentiated spermatogonia with RA stimulates the expression of Stra8 and of Kit, a marker of spermatogonial differentiation [148,149,150]. In vivo, Kit expression is low in undifferentiated spermatogonia due, in part, to the action of PLZF (also known as ZBTB16). In germ cells, PLZF maintains spermatogonia in an undifferentiated state [151,152] by binding the Kit promoter and repressing its expression [153] (Figure 4). At spermatogonial differentiation, RA induces the expression of its target gene Sall4, which sequesters PLZF from the Kit promoter, thereby increasing Kit expression (Figure 4) [154,155] (reviewed in [156]). RA has also been found to activate the PI3K-AKT-mTOR signaling cascade in a non-genomic manner, stimulating the translation of Kit mRNA [157] (reviewed in [158]). Thus, RA may induce spermatogonial differentiation via several independent pathways, including Stra8, Sall4, and Kit.
During spermatogonial differentiation, RA acts directly on germ cells through RARs. Undifferentiated spermatogonia express several RARs (Figure 4) [159,160], and simultaneous ablation of both RARγ and RARα in germ cells impairs spermatogonial differentiation [159] (reviewed in [145]). Additional targets of RA could be activated indirectly, by the action of RA on the Sertoli cells, as RA signaling via RARα in Sertoli cells is critical for the first round of spermatogonial differentiation [63], and for the differentiation of Sertoli cells at puberty [161].

3.4. Role of RA at the Initiation of Spermatid Elongation and Spermiation

In the 1980s, Huang and Marshall [162] suggested that vitamin A deficiency may delay spermiation. Moreover, ablation of RARs or RA-synthesizing enzymes (in germ cells and/or Sertoli cells) causes a variety of defects in both meiotic and postmeiotic transitions, including spermiation [63,163,164,165,166,167,168]. A recent study has shown that RA plays primary roles at two postmeiotic transitions; the initiation of spermatid elongation and spermiation (Figure 5) [19]. After injection of the inhibitor WIN18,446, both spermatid elongation and spermiation were delayed, and conversely, a single injection of RA was sufficient to precociously induce both these transitions.
It remains to be determined whether the requirement for RA at these two post-meiotic transitions is due to the direct action of RA on germ cells, or occurs indirectly, via Sertoli cells. RARs and RXRs are expressed specifically in round spermatids in stages VII and VIII [60], suggesting that RA may act directly on round spermatids to initiate elongation. Indirect RA signaling, via RARs/RXRs in Sertoli cells [60], may also contribute to this process. RA is likely to regulate the release of elongated spermatids indirectly, via Sertoli cells, as these spermatids are thought to be transcriptionally silent (reviewed in [169]). By identifying RA functions in post-meiotic cells, future studies may resolve the mechanism by which RA regulates each of these two postmeiotic transitions.

3.5. Source of RA in the Postnatal and Adult Testis

In postnatal and adult testes, RA-degrading enzymes (Cyp26a1, Cyp26b1, and Cyp26c1) are expressed by peritubular myoid cells that surround the seminiferous tubules [60]. These peritubular myoid cells form a catabolic barrier that prevents RA generated outside of the seminiferous epithelium from reaching the enclosed germ cells [156]. In the seminiferous tubule, RA is produced by two different cellular sources, Sertoli cells and germ cells. Sertoli cells express an RA-synthesizing enzyme, Aldh1a1 [60,170]. Another RA synthesizing enzyme, Aldh1a2, is expressed in pachytene and diplotene spermatocytes from stages VII through XII [60,170]. Indeed, direct quantitation of RA levels confirms that both Aldh1a1-expressing Sertoli cells and the Aldh1a2-expressing germ cells contribute to the total production of RA from circulating retinol [19,171].
The RA produced by Sertoli cells is required for spermatogonial differentiation. Sertoli cell-specific ablation of Aldh1a1-3 causes a complete arrest at the first round of spermatogonial differentiation in postnatal mice [63]. In the unperturbed testis, RA from Sertoli cells contributes functionally to both spermatogonial differentiation and meiotic initiation [19]. Recent studies have addressed the question of whether RA produced by pachytene spermatocytes is required for spermatogenesis [19,171,172]. Chemical or genetic depletion of pachytene spermatocytes in adult testes results in delays to both the elongation of the round spermatids and spermiation, but not to spermatogonial differentiation or meiotic initiation [19]. Germ cell-specific ablation of Aldh1a1-3 delays the first round of postnatal spermatogenesis, but these animals show complete spermatogenesis in adult testes at 8 to 10 weeks [171]. The simplest interpretation of these findings is that, in the unperturbed testis, pachytene spermatocytes work collaboratively with Sertoli cells to produce RA levels for the four transitions.
In mice with a Sertoli cell-specific deletion of Aldh1a1-3, the arrest at the first round of spermatogonial differentiation can be rescued by RA injection, as all germ cell cohorts are subsequently observed [63]. Conversely, after injection of RA at 4 weeks of age, Sertoli cell-specific Aldh1a1-3-deficient adults displayed abnormalities in spermiation at 24 weeks of age [63], suggesting that RA from Sertoli cells contributes modestly to this process. Moreover, the level of RA required for spermatogonial differentiation is higher than that required for meiotic initiation [171,172], indicating that each transition is sensitive to the local level of RA. Because the postmeiotic transitions are most sensitive following depletion of RA [19], the postmeiotic transitions may require a higher concentration of RA, from both Sertoli cells and pachytene spermatocytes, than the premeiotic transitions.
When mice lacking Aldh1a1-3 in both Sertoli cells and germ cells are given a single RA injection at P3, some germ cells immediately undergo spermatogonial differentiation and later initiate meiosis (with STRA8 expression) seven days after the injection [171]. Based on this observation, Teletin et al. [171] hypothesized that RA is dispensable for meiotic initiation. However, after a single injection of exogenous RA to postnatal mice, increased levels of RA in the testis are maintained for more than seven days, even under the daily treatment with WIN18,446, which inhibits endogenous RA production [172]. Given that meiotic initiation can be induced by a low threshold of RA [171,172], the injected RA remaining in the seminiferous tubule may be sufficient to induce meiotic initiation in postnatal mice.

3.6. Periodicity of Spermatogenesis and RA Levels

In the unperturbed testis, STRA8 is periodically expressed in spermatogonia and is present during the majority of the seminiferous cycle. Specifically, STRA8 is rarely expressed in stages II–VI (before the four transitions), then increases rapidly in stages VII–VIII (during transitions), and remains high thereafter in stages IX–I (Figure 5) [124,145,146]. The expression of STRA8 reflects the presence of RA; when RA levels are increased by injecting RA, or decreased by injecting WIN18,446, STRA8 expression is immediately induced or absent, respectively, in all seminiferous stages, as judged by immunostaining [124]. In good agreement with STRA8 expression, RA concentrations change periodically in the seminiferous tubule [124,146]; absolute quantification of RA levels has found that RA levels are low in stages II–VI, rise in stages VII–VIII, and remain high until stages XII/I (Figure 5) [124]. The expression of RA-metabolizing enzymes may help to explain how this periodicity of RA concentration is established in the adult testis. Aldh1a1 transcripts are present in stages I–VIII in Sertoli cells [156,170], and Aldh1a2 transcripts peak in late pachytene and diplotene spermatocytes in stages VII–XII [60,170]. Thus, Sertoli cell production of RA may precede the germ cell production of RA in each cycle of the seminiferous epithelium. In contrast, the expression of RA storage enzymes, Lrat and Adfp, which function to reduce local RA levels, are detected in stages I–VI/VII [60,170]. Thus, RA concentration in stages II-VI might be kept low, even in the presence of Aldh1a1. Moreover, the CYP26 family of enzymes, which are expressed in Sertoli cells [60,170,173,174], may catabolize RA to maintain tight control of the seminiferous milieu.

3.7. Competence of Germ Cells for Spermatogonial Differentiation

Despite the persistently elevated RA levels in stages IX–I, spermatogonial differentiation is not observed in these stages (Figure 5). Early undifferentiated As and Apr spermatogonia (found at all stages) and undifferentiated Aal spermatogonia in stages IX–I are unable to express STRA8 in response to RA injection, and do not undergo differentiation (Figure 5) [124]. In the presence of RA, these undifferentiated spermatogonia instead undertake self-renewal and proliferation, which prevents the pool of undifferentiated spermatogonia from being irreversibly depleted. This competence or incompetence for spermatogonial differentiation cannot simply be explained by the expression of RARs, as these receptors are broadly expressed across the seminiferous cycle [60,159,160]. Instead, competence for spermatogonial differentiation is more closely correlated with the proliferative activity of the cells. Specifically, undifferentiated spermatogonia in stages II–VIII, which are competent for differentiation [124], are arrested in the G0/G1 phase of the cell cycle, whereas undifferentiated spermatogonia in stages IX–I are actively proliferating (Figure 5) [107,117]. Further studies are needed to identify the mechanisms that confer competence for spermatogonia to undergo differentiation.

4. Summary and Perspectives

Several lines of evidence support a critical role for RA in directing meiotic initiation in the fetal ovary, and for critical transitions of adult spermatogenesis, including meiotic initiation. In development, embryonic germ cells acquire the competence to initiate meiosis in response to RA. Male germ cells, which escape from RA-induced meiotic initiation in the fetal testis by the catabolism of RA, develop first as undifferentiated spermatogonia, which later acquire competence for spermatogonial differentiation. Male germ cells subsequently acquire competence for meiotic initiation (and possibly initiation of spermatid elongation). These distinct competencies to respond to RA must be strictly regulated. After RA injection, undifferentiated spermatogonia are not competent to initiate meiosis directly; instead, the undifferentiated spermatogonia begin a program of spermatogonial differentiation, followed by six mitotic cell divisions [124]. Further studies of these distinct competencies will help our understanding of the basic mechanisms that govern germ cell development and advance assisted reproduction technologies, such as in vitro gamete production [175,176,177,178].

Author Contributions

Conceptualization, T.E.; writing-original draft and prepared the figures, T.E.; reviewing and editing the manuscript, T.E., M.M.M., P.K.N., D.C.P., and D.G.d.R.


T.E. is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant Number JP19K06439. M.M.M. is supported by a NRSA Postdoctoral Fellowship from the NICHD, Grant Number F32HD093391. D.C.P is an Investigator of the Howard Hughes Medical Institute.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Hacker, A.; Capel, B.; Goodfellow, P.; Lovell-Badge, R. Expression of Sry, the mouse sex determining gene. Development 1995, 121, 1603–1614. [Google Scholar] [PubMed]
  2. Schmahl, J.; Eicher, E.M.; Washburn, L.L.; Capel, B. Sry induces cell proliferation in the mouse gonad. Development 2000, 127, 65–73. [Google Scholar] [PubMed]
  3. Hu, Y.C.; Okumura, L.M.; Page, D.C. Gata4 is required for formation of the genital ridge in mice. PLoS Genet. 2013, 9, e1003629. [Google Scholar] [CrossRef]
  4. Hilscher, B.; Hilscher, W.; Bulthoff-Ohnolz, B.; Kramer, U.; Birke, A.; Pelzer, H.; Gauss, G. Kinetics of gametogenesis. I. Comparative histological and autoradiographic studies of oocytes and transitional prospermatogonia during oogenesis and prespermatogenesis. Cell Tissue Res. 1974, 154, 443–470. [Google Scholar]
  5. McLaren, A. Meiosis and differentiation of mouse germ cells. Symp. Soc. Exp. Biol. 1984, 38, 7–23. [Google Scholar]
  6. Byskov, A.G.; Saxen, L. Induction of meiosis in fetal mouse testis in vitro. Dev. Biol. 1976, 52, 193–200. [Google Scholar] [CrossRef]
  7. Koubova, J.; Menke, D.B.; Zhou, Q.; Capel, B.; Griswold, M.D.; Page, D.C. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc. Natl. Acad. Sci. USA 2006, 103, 2474–2479. [Google Scholar] [CrossRef]
  8. Bowles, J.; Knight, D.; Smith, C.; Wilhelm, D.; Richman, J.; Mamiya, S.; Yashiro, K.; Chawengsaksophak, K.; Wilson, M.J.; Rossant, J.; et al. Retinoid signaling determines germ cell fate in mice. Science 2006, 312, 596–600. [Google Scholar] [CrossRef]
  9. Bowles, J.; Feng, C.W.; Miles, K.; Ineson, J.; Spiller, C.; Koopman, P. ALDH1A1 provides a source of meiosis-inducing retinoic acid in mouse fetal ovaries. Nat. Commun. 2016, 7, 10845. [Google Scholar] [CrossRef]
  10. Abu-Abed, S.; Dolle, P.; Metzger, D.; Beckett, B.; Chambon, P.; Petkovich, M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev. 2001, 15, 226–240. [Google Scholar] [CrossRef]
  11. Niederreither, K.; Abu-Abed, S.; Schuhbaur, B.; Petkovich, M.; Chambon, P.; Dolle, P. Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat. Genet. 2002, 31, 84–88. [Google Scholar] [CrossRef] [PubMed]
  12. Niederreither, K.; Dolle, P. Retinoic acid in development: Towards an integrated view. Nat. Rev. Genet. 2008, 9, 541–553. [Google Scholar] [CrossRef] [PubMed]
  13. Duester, G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134, 921–931. [Google Scholar] [CrossRef] [PubMed]
  14. Clermont, Y.; Perey, B. Quantitative study of the cell population of the seminiferous tubules in immature rats. Am. J. Anat. 1957, 100, 241–267. [Google Scholar] [CrossRef]
  15. Huckins, C.; Clermont, Y. Evolution of gonocytes in the rat testis during late embryonic and early post-natal life. Arch. Anat. Histol. Embryol. 1968, 51, 341–354. [Google Scholar]
  16. Russell, L.D.; Ettlin, R.A.; Sinha Hikim, A.P.; Clegg, E.D. Histological and Histopathological Evaluation of the Testis; Cache River Press: Clearwater, FL, USA, 1990. [Google Scholar]
  17. van Pelt, A.M.; de Rooij, D.G. Retinoic acid is able to reinitiate spermatogenesis in vitamin A-deficient rats and high replicate doses support the full development of spermatogenic cells. Endocrinology 1991, 128, 697–704. [Google Scholar] [CrossRef]
  18. Anderson, E.L.; Baltus, A.E.; Roepers-Gajadien, H.L.; Hassold, T.J.; de Rooij, D.G.; van Pelt, A.M.; Page, D.C. Stra8 and its inducer, retinoic acid, regulate meiotic initiation in both spermatogenesis and oogenesis in mice. Proc. Natl. Acad. Sci. USA 2008, 105, 14976–14980. [Google Scholar] [CrossRef]
  19. Endo, T.; Freinkman, E.; de Rooij, D.G.; Page, D.C. Periodic production of retinoic acid by meiotic and somatic cells coordinates four transitions in mouse spermatogenesis. Proc. Natl. Acad. Sci. USA 2017, 114, E10132–E10141. [Google Scholar] [CrossRef]
  20. McLaren, A. Primordial germ cells in the mouse. Dev. Biol. 2003, 262, 1–15. [Google Scholar] [CrossRef]
  21. Brambell, F.W.R. The development and morphology of the gonads of the mouse - Part I The morphogenesis of the indifferent gonad and of the ovary. Proc. R. Soc. B 1927, 101, 391–409. [Google Scholar] [CrossRef]
  22. Tam, P.P.; Snow, M.H. Proliferation and migration of primordial germ cells during compensatory growth in mouse embryos. J. Embryol. Exp. Morphol. 1981, 64, 133–147. [Google Scholar] [PubMed]
  23. Sapford, C.S. Changes in the cells of the Sex Cords and Seminiferous Tubules during the development of the Testis of the rat and mouse. Aust. J. Zool. 1962, 10, 178–192. [Google Scholar] [CrossRef]
  24. Nicholls, P.K.; Schorle, H.; Naqvi, S.; Hu, Y.C.; Fan, Y.; Carmell, M.A.; Dobrinski, I.; Watson, A.L.; Carlson, D.F.; Fahrenkrug, S.C.; et al. Mammalian germ cells are determined after PGC colonization of the nascent gonad. Proc. Natl. Acad. Sci. USA 2019. [Google Scholar] [CrossRef]
  25. Pesce, M.; Wang, X.; Wolgemuth, D.J.; Scholer, H. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech. Dev. 1998, 71, 89–98. [Google Scholar] [CrossRef]
  26. Bullejos, M.; Koopman, P. Germ cells enter meiosis in a rostro-caudal wave during development of the mouse ovary. Mol. Reprod. Dev. 2004, 68, 422–428. [Google Scholar] [CrossRef]
  27. Stevens, L.C. Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J. Natl. Cancer Inst. 1966, 37, 859–867. [Google Scholar]
  28. Matsui, Y.; Tokitake, Y. Primordial germ cells contain subpopulations that have greater ability to develop into pluripotential stem cells. Dev. Growth Differ. 2009, 51, 657–667. [Google Scholar] [CrossRef]
  29. McLaren, A.; Southee, D. Entry of mouse embryonic germ cells into meiosis. Dev. Biol. 1997, 187, 107–113. [Google Scholar] [CrossRef]
  30. Adams, I.R.; McLaren, A. Sexually dimorphic development of mouse primordial germ cells: Switching from oogenesis to spermatogenesis. Development 2002, 129, 1155–1164. [Google Scholar]
  31. Gill, M.E.; Hu, Y.C.; Lin, Y.; Page, D.C. Licensing of gametogenesis, dependent on RNA binding protein DAZL, as a gateway to sexual differentiation of fetal germ cells. Proc. Natl. Acad. Sci. USA 2011, 108, 7443–7448. [Google Scholar] [CrossRef]
  32. Hu, Y.C.; Nicholls, P.K.; Soh, Y.Q.; Daniele, J.R.; Junker, J.P.; van Oudenaarden, A.; Page, D.C. Licensing of primordial germ cells for gametogenesis depends on genital ridge signaling. PLoS Genet. 2015, 11, e1005019. [Google Scholar] [CrossRef] [PubMed]
  33. Seligman, J.; Page, D.C. The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. Biochem. Biophys. Res. Commun. 1998, 245, 878–882. [Google Scholar] [CrossRef] [PubMed]
  34. Chen, H.H.; Welling, M.; Bloch, D.B.; Munoz, J.; Mientjes, E.; Chen, X.; Tramp, C.; Wu, J.; Yabuuchi, A.; Chou, Y.F.; et al. DAZL limits pluripotency, differentiation, and apoptosis in developing primordial germ cells. Stem Cell Rep. 2014, 3, 892–904. [Google Scholar] [CrossRef] [PubMed]
  35. Lin, Y.; Gill, M.E.; Koubova, J.; Page, D.C. Germ cell-intrinsic and -extrinsic factors govern meiotic initiation in mouse embryos. Science 2008, 322, 1685–1687. [Google Scholar] [CrossRef]
  36. Baltus, A.E.; Menke, D.B.; Hu, Y.C.; Goodheart, M.L.; Carpenter, A.E.; de Rooij, D.G.; Page, D.C. In germ cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication. Nat. Genet. 2006, 38, 1430–1434. [Google Scholar] [CrossRef]
  37. Bannister, L.A.; Reinholdt, L.G.; Munroe, R.J.; Schimenti, J.C. Positional cloning and characterization of mouse mei8, a disrupted allelle of the meiotic cohesin Rec8. Genesis 2004, 40, 184–194. [Google Scholar] [CrossRef]
  38. Xu, H.; Beasley, M.D.; Warren, W.D.; van der Horst, G.T.; McKay, M.J. Absence of mouse REC8 cohesin promotes synapsis of sister chromatids in meiosis. Dev. Cell 2005, 8, 949–961. [Google Scholar] [CrossRef] [Green Version]
  39. Koubova, J.; Hu, Y.C.; Bhattacharyya, T.; Soh, Y.Q.; Gill, M.E.; Goodheart, M.L.; Hogarth, C.A.; Griswold, M.D.; Page, D.C. Retinoic Acid activates two pathways required for meiosis in mice. PLoS Genet. 2014, 10, e1004541. [Google Scholar] [CrossRef] [Green Version]
  40. Menke, D.B.; Koubova, J.; Page, D.C. Sexual differentiation of germ cells in XX mouse gonads occurs in an anterior-to-posterior wave. Dev. Biol. 2003, 262, 303–312. [Google Scholar] [CrossRef] [Green Version]
  41. Soh, Y.Q.; Junker, J.P.; Gill, M.E.; Mueller, J.L.; van Oudenaarden, A.; Page, D.C. A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. PLoS Genet. 2015, 11, e1005531. [Google Scholar] [CrossRef] [Green Version]
  42. Yao, H.H.; DiNapoli, L.; Capel, B. Meiotic germ cells antagonize mesonephric cell migration and testis cord formation in mouse gonads. Development 2003, 130, 5895–5902. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Western, P.S.; van den Bergen, J.A.; Miles, D.C.; Sinclair, A.H. Male fetal germ cell differentiation involves complex repression of the regulatory network controlling pluripotency. FASEB J. 2010, 24, 3026–3035. [Google Scholar] [CrossRef] [PubMed]
  44. Ginsburg, M.; Snow, M.H.; McLaren, A. Primordial germ cells in the mouse embryo during gastrulation. Development 1990, 110, 521–528. [Google Scholar] [PubMed]
  45. Kojima, M.L.; de Rooij, D.G.; Page, D.C. Amplification of a broad transcriptional program by a common factor triggers the meiotic cell cycle in mice. Elife 2019, 8, e43738. [Google Scholar] [CrossRef]
  46. Oulad-Abdelghani, M.; Bouillet, P.; Decimo, D.; Gansmuller, A.; Heyberger, S.; Dolle, P.; Bronner, S.; Lutz, Y.; Chambon, P. Characterization of a premeiotic germ cell-specific cytoplasmic protein encoded by Stra8, a novel retinoic acid-responsive gene. J. Cell Biol. 1996, 135, 469–477. [Google Scholar] [CrossRef]
  47. Zhou, Q.; Nie, R.; Li, Y.; Friel, P.; Mitchell, D.; Hess, R.A.; Small, C.; Griswold, M.D. Expression of stimulated by retinoic acid gene 8 (Stra8) in spermatogenic cells induced by retinoic acid: An in vivo study in vitamin A-sufficient postnatal murine testes. Biol. Reprod. 2008, 79, 35–42. [Google Scholar] [CrossRef] [Green Version]
  48. Zhou, Q.; Li, Y.; Nie, R.; Friel, P.; Mitchell, D.; Evanoff, R.M.; Pouchnik, D.; Banasik, B.; McCarrey, J.R.; Small, C.; et al. Expression of stimulated by retinoic acid gene 8 (Stra8) and maturation of murine gonocytes and spermatogonia induced by retinoic acid in vitro. Biol. Reprod. 2008, 78, 537–545. [Google Scholar] [CrossRef]
  49. Li, H.; Clagett-Dame, M. Vitamin A deficiency blocks the initiation of meiosis of germ cells in the developing rat ovary in vivo. Biol. Reprod. 2009, 81, 996–1001. [Google Scholar] [CrossRef] [Green Version]
  50. Allenby, G.; Bocquel, M.T.; Saunders, M.; Kazmer, S.; Speck, J.; Rosenberger, M.; Lovey, A.; Kastner, P.; Grippo, J.F.; Chambon, P.; et al. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 1993, 90, 30–34. [Google Scholar] [CrossRef] [Green Version]
  51. Ruhl, R.; Krzyzosiak, A.; Niewiadomska-Cimicka, A.; Rochel, N.; Szeles, L.; Vaz, B.; Wietrzych-Schindler, M.; Alvarez, S.; Szklenar, M.; Nagy, L.; et al. 9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice. PLoS Genet. 2015, 11, e1005213. [Google Scholar] [CrossRef] [Green Version]
  52. Ruhl, R.; Krezel, W.; de Lera, A.R. 9-Cis-13,14-dihydroretinoic acid, a new endogenous mammalian ligand of retinoid X receptor and the active ligand of a potential new vitamin A category: Vitamin A5. Nutr. Rev. 2018, 76, 929–941. [Google Scholar] [CrossRef] [PubMed]
  53. Dawson, M.I.; Xia, Z. The retinoid X receptors and their ligands. Biochim. Biophys. Acta 2012, 1821, 21–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10, 940–954. [Google Scholar] [CrossRef] [PubMed]
  55. Evans, R.M.; Mangelsdorf, D.J. Nuclear Receptors, RXR, and the Big Bang. Cell 2014, 157, 255–266. [Google Scholar] [CrossRef] [Green Version]
  56. Mark, M.; Ghyselinck, N.B.; Chambon, P. Function of retinoic acid receptors during embryonic development. Nucl. Recept. Signal. 2009, 7, e002. [Google Scholar] [CrossRef] [Green Version]
  57. Kastner, P.; Mark, M.; Chambon, P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 1995, 83, 859–869. [Google Scholar] [CrossRef] [Green Version]
  58. Morita, Y.; Tilly, J.L. Segregation of retinoic acid effects on fetal ovarian germ cell mitosis versus apoptosis by requirement for new macromolecular synthesis. Endocrinology 1999, 140, 2696–2703. [Google Scholar] [CrossRef]
  59. Dolle, P.; Ruberte, E.; Leroy, P.; Morriss-Kay, G.; Chambon, P. Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 1990, 110, 1133–1151. [Google Scholar]
  60. Vernet, N.; Dennefeld, C.; Rochette-Egly, C.; Oulad-Abdelghani, M.; Chambon, P.; Ghyselinck, N.B.; Mark, M. Retinoic acid metabolism and signaling pathways in the adult and developing mouse testis. Endocrinology 2006, 147, 96–110. [Google Scholar] [CrossRef] [Green Version]
  61. Boulogne, B.; Levacher, C.; Durand, P.; Habert, R. Retinoic acid receptors and retinoid X receptors in the rat testis during fetal and postnatal development: Immunolocalization and implication in the control of the number of gonocytes. Biol. Reprod. 1999, 61, 1548–1557. [Google Scholar] [CrossRef] [Green Version]
  62. Childs, A.J.; Cowan, G.; Kinnell, H.L.; Anderson, R.A.; Saunders, P.T. Retinoic Acid signalling and the control of meiotic entry in the human fetal gonad. PLoS ONE 2011, 6, e20249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Raverdeau, M.; Gely-Pernot, A.; Feret, B.; Dennefeld, C.; Benoit, G.; Davidson, I.; Chambon, P.; Mark, M.; Ghyselinck, N.B. Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis. Proc. Natl. Acad. Sci. USA 2012, 109, 16582–16587. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Zhao, X.; Sirbu, I.O.; Mic, F.A.; Molotkova, N.; Molotkov, A.; Kumar, S.; Duester, G. Retinoic acid promotes limb induction through effects on body axis extension but is unnecessary for limb patterning. Curr. Biol. 2009, 19, 1050–1057. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Kumar, S.; Chatzi, C.; Brade, T.; Cunningham, T.J.; Zhao, X.; Duester, G. Sex-specific timing of meiotic initiation is regulated by Cyp26b1 independent of retinoic acid signalling. Nat. Commun. 2011, 2, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Mu, X.; Wen, J.; Guo, M.; Wang, J.; Li, G.; Wang, Z.; Wang, Y.; Teng, Z.; Cui, Y.; Xia, G. Retinoic acid derived from the fetal ovary initiates meiosis in mouse germ cells. J. Cell Physiol. 2013, 228, 627–639. [Google Scholar] [CrossRef]
  67. Bowles, J.; Feng, C.W.; Knight, D.; Smith, C.A.; Roeszler, K.N.; Bagheri-Fam, S.; Harley, V.R.; Sinclair, A.H.; Koopman, P. Male-specific expression of Aldh1a1 in mouse and chicken fetal testes: Implications for retinoid balance in gonad development. Dev. Dyn. 2009, 238, 2073–2080. [Google Scholar] [CrossRef]
  68. Fan, X.; Molotkov, A.; Manabe, S.; Donmoyer, C.M.; Deltour, L.; Foglio, M.H.; Cuenca, A.E.; Blaner, W.S.; Lipton, S.A.; Duester, G. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell Biol. 2003, 23, 4637–4648. [Google Scholar] [CrossRef] [Green Version]
  69. Bowles, J.; Koopman, P. Retinoic acid, meiosis and germ cell fate in mammals. Development 2007, 134, 3401–3411. [Google Scholar] [CrossRef] [Green Version]
  70. Spiller, C.; Koopman, P.; Bowles, J. Sex Determination in the Mammalian Germline. Annu. Rev. Genet. 2017, 51, 265–285. [Google Scholar] [CrossRef]
  71. Byskov, A.G. The anatomy and ultrastructure of the rete system in the fetal mouse ovary. Biol. Reprod. 1978, 19, 720–735. [Google Scholar] [CrossRef]
  72. Karl, J.; Capel, B. Three-dimensional structure of the developing mouse genital ridge. Philos. Trans. R Soc. Lond. B Biol. Sci. 1995, 350, 235–242. [Google Scholar] [PubMed]
  73. Miyauchi, H.; Ohta, H.; Nagaoka, S.; Nakaki, F.; Sasaki, K.; Hayashi, K.; Yabuta, Y.; Nakamura, T.; Yamamoto, T.; Saitou, M. Bone morphogenetic protein and retinoic acid synergistically specify female germ-cell fate in mice. EMBO J. 2017, 36, 3100–3119. [Google Scholar] [CrossRef] [PubMed]
  74. Abu-Abed, S.; MacLean, G.; Fraulob, V.; Chambon, P.; Petkovich, M.; Dolle, P. Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev. 2002, 110, 173–177. [Google Scholar] [CrossRef]
  75. Menke, D.B.; Page, D.C. Sexually dimorphic gene expression in the developing mouse gonad. Gene Expr. Patterns 2002, 2, 359–367. [Google Scholar] [CrossRef]
  76. MacLean, G.; Li, H.; Metzger, D.; Chambon, P.; Petkovich, M. Apoptotic extinction of germ cells in testes of Cyp26b1 knockout mice. Endocrinology 2007, 148, 4560–4567. [Google Scholar] [PubMed] [Green Version]
  77. Suzuki, A.; Saga, Y. Nanos2 suppresses meiosis and promotes male germ cell differentiation. Genes Dev. 2008, 22, 430–435. [Google Scholar] [CrossRef] [Green Version]
  78. Suzuki, A.; Igarashi, K.; Aisaki, K.; Kanno, J.; Saga, Y. NANOS2 interacts with the CCR4-NOT deadenylation complex and leads to suppression of specific RNAs. Proc. Natl. Acad. Sci. USA 2010, 107, 3594–3599. [Google Scholar] [CrossRef] [Green Version]
  79. Kato, Y.; Katsuki, T.; Kokubo, H.; Masuda, A.; Saga, Y. Dazl is a target RNA suppressed by mammalian NANOS2 in sexually differentiating male germ cells. Nat. Commun. 2016, 7, 11272. [Google Scholar] [CrossRef] [Green Version]
  80. Saga, Y. Function of Nanos2 in the male germ cell lineage in mice. Cell. Mol. Life Sci. 2010, 67, 3815–3822. [Google Scholar] [CrossRef]
  81. Suzuki, A.; Hirasaki, M.; Okuda, A. Does MAX open up a new avenue for meiotic research? Dev. Growth Differ. 2017, 59, 61–69. [Google Scholar] [CrossRef] [Green Version]
  82. Lehmann, R.; Nusslein-Volhard, C. The maternal gene nanos has a central role in posterior pattern formation of the Drosophila embryo. Development 1991, 112, 679–691. [Google Scholar] [PubMed]
  83. Tsuda, M.; Sasaoka, Y.; Kiso, M.; Abe, K.; Haraguchi, S.; Kobayashi, S.; Saga, Y. Conserved role of nanos proteins in germ cell development. Science 2003, 301, 1239–1241. [Google Scholar] [PubMed]
  84. Eppig, J.J. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001, 122, 829–838. [Google Scholar] [PubMed]
  85. Handel, M.A.; Eppig, J.J. Sexual dimorphism in the regulation of mammalian meiosis. Curr. Top Dev. Biol. 1998, 37, 333–358. [Google Scholar] [PubMed]
  86. Bolcun-Filas, E.; Handel, M.A. Meiosis: The chromosomal foundation of reproduction. Biol. Reprod. 2018, 99, 112–126. [Google Scholar] [CrossRef] [Green Version]
  87. Dokshin, G.A.; Baltus, A.E.; Eppig, J.J.; Page, D.C. Oocyte differentiation is genetically dissociable from meiosis in mice. Nat. Genet. 2013, 45, 877–883. [Google Scholar] [CrossRef] [Green Version]
  88. Su, Y.Q.; Sugiura, K.; Eppig, J.J. Mouse oocyte control of granulosa cell development and function: Paracrine regulation of cumulus cell metabolism. Semin. Reprod. Med. 2009, 27, 32–42. [Google Scholar] [CrossRef] [Green Version]
  89. Duque, P.; Diez, C.; Royo, L.; Lorenzo, P.L.; Carneiro, G.; Hidalgo, C.O.; Facal, N.; Gomez, E. Enhancement of developmental capacity of meiotically inhibited bovine oocytes by retinoic acid. Hum. Reprod. 2002, 17, 2706–2714. [Google Scholar]
  90. Gomez, E.; Royo, L.J.; Duque, P.; Carneiro, G.; Hidalgo, C.; Goyache, F.; Lorenzo, P.L.; Alvarez, I.; Facal, N.; Diez, C. 9-cis-retinoic acid during in vitro maturation improves development of the bovine oocyte and increases midkine but not IGF-I expression in cumulus-granulosa cells. Mol. Reprod. Dev. 2003, 66, 247–255. [Google Scholar] [CrossRef]
  91. Hidalgo, C.O.; Diez, C.; Duque, P.; Facal, N.; Gomez, E. Pregnancies and improved early embryonic development with bovine oocytes matured in vitro with 9-cis-retinoic acid. Reproduction 2003, 125, 409–416. [Google Scholar]
  92. Deb, G.K.; Dey, S.R.; Bang, J.I.; Lee, J.G.; Kong, I.K. 9-cis Retinoic acid inhibits cumulus cell apoptosis during the maturation of bovine cumulus-oocyte-complexes. J. Anim. Sci. 2012, 90, 1798–1806. [Google Scholar] [CrossRef] [PubMed]
  93. Read, C.C.; Dyce, P.W. All-trans retinoic acid exposure increases connexin 43 expression in cumulus cells and improves embryo development in bovine oocytes. Mol. Reprod. Dev. 2019. [Google Scholar] [CrossRef] [PubMed]
  94. Pu, Y.; Wang, Z.; Bian, Y.; Zhang, F.; Yang, P.; Li, Y.; Zhang, Y.; Liu, Y.; Fang, F.; Cao, H.; et al. All-trans retinoic acid improves goat oocyte nuclear maturation and reduces apoptotic cumulus cells during in vitro maturation. Anim. Sci. J. 2014, 85, 833–839. [Google Scholar] [CrossRef] [PubMed]
  95. Alminana, C.; Gil, M.A.; Cuello, C.; Caballero, I.; Roca, J.; Vazquez, J.M.; Gomez, E.; Martinez, E.A. In vitro maturation of porcine oocytes with retinoids improves embryonic development. Reprod. Fertil. Dev. 2008, 20, 483–489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Suwa, H.; Kishi, H.; Imai, F.; Nakao, K.; Hirakawa, T.; Minegishi, T. Retinoic acid enhances progesterone production via the cAMP/PKA signaling pathway in immature rat granulosa cells. Biochem. Biophys. Rep. 2016, 8, 62–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Tahaei, L.S.; Eimani, H.; Yazdi, P.E.; Ebrahimi, B.; Fathi, R. Effects of retinoic acid on maturation of immature mouse oocytes in the presence and absence of a granulosa cell co-culture system. J. Assist. Reprod. Genet. 2011, 28, 553–558. [Google Scholar] [CrossRef] [Green Version]
  98. Nasiri, E.; Mahmoudi, R.; Bahadori, M.H.; Amiri, I. The Effect of Retinoic Acid on in vitro Maturation and Fertilization Rate of Mouse Germinal Vesicle Stage Oocytes. Cell J. 2011, 13, 19–24. [Google Scholar]
  99. Ikeda, S.; Kitagawa, M.; Imai, H.; Yamada, M. The roles of vitamin A for cytoplasmic maturation of bovine oocytes. J. Reprod. Dev. 2005, 51, 23–35. [Google Scholar] [CrossRef] [Green Version]
  100. Gomez, E.; Caamano, J.N.; Rodriguez, A.; De Frutos, C.; Facal, N.; Diez, C. Bovine early embryonic development and vitamin A. Reprod. Domest. Anim. 2006, 41, 63–71. [Google Scholar] [CrossRef] [Green Version]
  101. Mohan, M.; Thirumalapura, N.R.; Malayer, J. Bovine cumulus-granulosa cells contain biologically active retinoid receptors that can respond to retinoic acid. Reprod. Biol. Endocrinol. 2003, 1, 104. [Google Scholar] [CrossRef] [Green Version]
  102. Kawai, T.; Yanaka, N.; Richards, J.S.; Shimada, M. De Novo-Synthesized Retinoic Acid in Ovarian Antral Follicles Enhances FSH-Mediated Ovarian Follicular Cell Differentiation and Female Fertility. Endocrinology 2016, 157, 2160–2172. [Google Scholar] [CrossRef] [PubMed]
  103. Minegishi, T.; Karino, S.; Tano, M.; Ibuki, Y.; Miyamoto, K. Regulation of midkine messenger ribonucleic acid levels in cultured rat granulosa cells. Biochem. Biophys. Res. Commun. 1996, 229, 799–805. [Google Scholar] [CrossRef] [PubMed]
  104. Hattori, M.; Takesue, K.; Nishida, N.; Kato, Y.; Fujihara, N. Inhibitory effect of retinoic acid on the development of immature porcine granulosa cells to mature cells. J. Mol. Endocrinol. 2000, 25, 53–61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Novi, A.M.; Saba, P. An electron microscopic study of the development of rat testis in the first 10 postnatal days. Z Zellforsch Mikrosk Anat 1968, 86, 313–326. [Google Scholar] [CrossRef] [PubMed]
  106. Oakberg, E.F. A description of spermiogenesis in the mouse and its use in analysis of the cycle of the seminiferous epithelium and germ cell renewal. Am. J. Anat. 1956, 99, 391–413. [Google Scholar] [CrossRef]
  107. Oakberg, E.F. Spermatogonial stem-cell renewal in the mouse. Anat. Rec. 1971, 169, 515–531. [Google Scholar] [CrossRef]
  108. de Rooij, D.G. Spermatogonial stem cell renewal in the mouse. I. Normal situation. Cell Tissue Kinet. 1973, 6, 281–287. [Google Scholar] [CrossRef]
  109. Nakagawa, T.; Nabeshima, Y.; Yoshida, S. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev. Cell 2007, 12, 195–206. [Google Scholar] [CrossRef] [Green Version]
  110. Chan, F.; Oatley, M.J.; Kaucher, A.V.; Yang, Q.E.; Bieberich, C.J.; Shashikant, C.S.; Oatley, J.M. Functional and molecular features of the Id4+ germline stem cell population in mouse testes. Genes Dev. 2014, 28, 1351–1362. [Google Scholar] [CrossRef] [Green Version]
  111. de Rooij, D.G. Stem cells in the testis. Int. J. Exp. Pathol. 1998, 79, 67–80. [Google Scholar] [CrossRef]
  112. Huckins, C. The spermatogonial stem cell population in adult rats. I. Their morphology, proliferation and maturation. Anat. Rec. 1971, 169, 533–557. [Google Scholar] [CrossRef] [PubMed]
  113. de Rooij, D.G. The nature and dynamics of spermatogonial stem cells. Development 2017, 144, 3022–3030. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. de Rooij, D.G.; Russell, L.D. All you wanted to know about spermatogonia but were afraid to ask. J. Androl. 2000, 21, 776–798. [Google Scholar] [PubMed]
  115. de Rooij, D.G. Proliferation and differentiation of spermatogonial stem cells. Reproduction 2001, 121, 347–354. [Google Scholar] [CrossRef] [PubMed]
  116. Shinohara, T.; Orwig, K.E.; Avarbock, M.R.; Brinster, R.L. Spermatogonial stem cell enrichment by multiparameter selection of mouse testis cells. Proc. Natl. Acad. Sci. USA 2000, 97, 8346–8351. [Google Scholar] [CrossRef] [Green Version]
  117. Lok, D.; de Rooij, D.G. Spermatogonial multiplication in the Chinese hamster. III. Labelling indices of undifferentiated spermatogonia throughout the cycle of the seminiferous epithelium. Cell Tissue Kinet. 1983, 16, 31–40. [Google Scholar]
  118. Monesi, V. Autoradiographic study of DNA synthesis and the cell cycle in spermatogonia and spermatocytes of mouse testis using tritiated thymidine. J. Cell Biol. 1962, 14, 1–18. [Google Scholar] [CrossRef] [Green Version]
  119. O’Donnell, L.; Nicholls, P.K.; O’Bryan, M.K.; McLachlan, R.I.; Stanton, P.G. Spermiation: The process of sperm release. Spermatogenesis 2011, 1, 14–35. [Google Scholar] [CrossRef]
  120. Sylvester, S.R.; Griswold, M.D. The testicular iron shuttle: A “nurse” function of the Sertoli cells. J. Androl. 1994, 15, 381–385. [Google Scholar]
  121. Franca, L.R.; Hess, R.A.; Dufour, J.M.; Hofmann, M.C.; Griswold, M.D. The Sertoli cell: One hundred fifty years of beauty and plasticity. Andrology 2016, 4, 189–212. [Google Scholar] [CrossRef] [Green Version]
  122. Oakberg, E.F. Duration of spermatogenesis in the mouse and timing of stages of the cycle of the seminiferous epithelium. Am. J. Anat. 1956, 99, 507–516. [Google Scholar] [CrossRef] [PubMed]
  123. Mruk, D.D.; Cheng, C.Y. Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr. Rev. 2004, 25, 747–806. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Endo, T.; Romer, K.A.; Anderson, E.L.; Baltus, A.E.; de Rooij, D.G.; Page, D.C. Periodic retinoic acid-STRA8 signaling intersects with periodic germ-cell competencies to regulate spermatogenesis. Proc. Natl. Acad. Sci. USA 2015, 112, E2347–E2356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Muciaccia, B.; Boitani, C.; Berloco, B.P.; Nudo, F.; Spadetta, G.; Stefanini, M.; de Rooij, D.G.; Vicini, E. Novel stage classification of human spermatogenesis based on acrosome development. Biol. Reprod. 2013, 89, 60. [Google Scholar] [CrossRef] [PubMed]
  126. Leblond, C.P.; Clermont, Y. Spermiogenesis of rat, mouse, hamster and guinea pig as revealed by the “periodic acid-fuchsin sulfurous acid” technique. Am J Anat 1952, 90, 167–215. [Google Scholar] [CrossRef]
  127. Lok, D.; Weenk, D.; De Rooij, D.G. Morphology, proliferation, and differentiation of undifferentiated spermatogonia in the Chinese hamster and the ram. Anat. Rec. 1982, 203, 83–99. [Google Scholar] [CrossRef]
  128. Wolbach, S.B.; Howe, P.R. Tissue Changes Following Deprivation of Fat-Soluble a Vitamin. J. Exp. Med. 1925, 42, 753–777. [Google Scholar] [CrossRef] [Green Version]
  129. Mason, K.E. Differences in testis injury and repair after vitamin A-deficiency, vitamin E-deficiency, and inanition. Am. J. Anat. 1933, 52, 153–239. [Google Scholar] [CrossRef]
  130. Thompson, J.N.; Howell, J.M.; Pitt, G.A. Vitamin a and Reproduction in Rats. Proc R Soc Lond B Biol Sci 1964, 159, 510–535. [Google Scholar]
  131. Livera, G.; Rouiller-Fabre, V.; Pairault, C.; Levacher, C.; Habert, R. Regulation and perturbation of testicular functions by vitamin A. Reproduction 2002, 124, 173–180. [Google Scholar] [CrossRef]
  132. Hogarth, C.A.; Griswold, M.D. Driving asynchronous spermatogenesis: Is retinoic acid the answer? Anim. Reprod. 2012, 9, 742–750. [Google Scholar]
  133. Mitranond, V.; Sobhon, P.; Tosukhowong, P.; Chindaduangrat, W. Cytological changes in the testes of vitamin-A-deficient rats. I. Quantitation of germinal cells in the seminiferous tubules. Acta Anat. 1979, 103, 159–168. [Google Scholar] [CrossRef] [PubMed]
  134. Unni, E.; Rao, M.R.; Ganguly, J. Histological & ultrastructural studies on the effect of vitamin A depletion & subsequent repletion with vitamin A on germ cells & Sertoli cells in rat testis. Indian J. Exp. Biol. 1983, 21, 180–192. [Google Scholar] [PubMed]
  135. Morales, C.; Griswold, M.D. Retinol-induced stage synchronization in seminiferous tubules of the rat. Endocrinology 1987, 121, 432–434. [Google Scholar] [CrossRef] [PubMed]
  136. van Pelt, A.M.; De Rooij, D.G. The origin of the synchronization of the seminiferous epithelium in vitamin A-deficient rats after vitamin A replacement. Biol. Reprod. 1990, 42, 677–682. [Google Scholar] [CrossRef]
  137. van Pelt, A.M.; de Rooij, D.G. Synchronization of the seminiferous epithelium after vitamin A replacement in vitamin A-deficient mice. Biol. Reprod. 1990, 43, 363–367. [Google Scholar] [CrossRef] [Green Version]
  138. Huang, H.F.; Hembree, W.C. Spermatogenic response to vitamin A in vitamin A deficient rats. Biol. Reprod. 1979, 21, 891–904. [Google Scholar] [CrossRef] [Green Version]
  139. Amory, J.K.; Muller, C.H.; Shimshoni, J.A.; Isoherranen, N.; Paik, J.; Moreb, J.S.; Amory, D.W., Sr.; Evanoff, R.; Goldstein, A.S.; Griswold, M.D. Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis. J. Androl. 2011, 32, 111–119. [Google Scholar] [CrossRef] [Green Version]
  140. Hogarth, C.A.; Evanoff, R.; Snyder, E.; Kent, T.; Mitchell, D.; Small, C.; Amory, J.; Griswold, M.D. Suppression of Stra8 Expression in the Mouse Gonad by WIN 18,446. Biol. Reprod. 2011, 84, 957–965. [Google Scholar] [CrossRef] [Green Version]
  141. Brooks, N.L.; van der Horst, G. Short-term effects of N’N-bis(dichloroacetyl)-1,8-octamethylenediamine (WIN 18446) on the testes, selected sperm parameters and fertility of male CBA mice. Lab Anim. 2003, 37, 363–373. [Google Scholar] [CrossRef]
  142. Hogarth, C.A.; Evanoff, R.; Mitchell, D.; Kent, T.; Small, C.; Amory, J.K.; Griswold, M.D. Turning a spermatogenic wave into a tsunami: Synchronizing murine spermatogenesis using WIN 18,446. Biol. Reprod. 2013, 88, 40. [Google Scholar] [CrossRef] [PubMed]
  143. Snyder, E.M.; Small, C.; Griswold, M.D. Retinoic acid availability drives the asynchronous initiation of spermatogonial differentiation in the mouse. Biol. Reprod. 2010, 83, 783–790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  144. Drumond, A.L.; Meistrich, M.L.; Chiarini-Garcia, H. Spermatogonial morphology and kinetics during testis development in mice: A high-resolution light microscopy approach. Reproduction 2011, 142, 145–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Mark, M.; Teletin, M.; Vernet, N.; Ghyselinck, N.B. Role of retinoic acid receptor (RAR) signaling in post-natal male germ cell differentiation. Biochim. et Biophys. Acta 2015, 1849, 84–93. [Google Scholar] [CrossRef] [PubMed]
  146. Hogarth, C.A.; Arnold, S.; Kent, T.; Mitchell, D.; Isoherranen, N.; Griswold, M.D. Processive pulses of retinoic acid propel asynchronous and continuous murine sperm production. Biol. Reprod. 2015, 92, 37. [Google Scholar] [CrossRef] [Green Version]
  147. Pellegrini, M.; Filipponi, D.; Gori, M.; Barrios, F.; Lolicato, F.; Grimaldi, P.; Rossi, P.; Jannini, E.A.; Geremia, R.; Dolci, S. ATRA and KL promote differentiation toward the meiotic program of male germ cells. Cell Cycle 2008, 7, 3878–3888. [Google Scholar] [CrossRef] [Green Version]
  148. Yoshinaga, K.; Nishikawa, S.; Ogawa, M.; Hayashi, S.; Kunisada, T.; Fujimoto, T. Role of c-kit in mouse spermatogenesis: Identification of spermatogonia as a specific site of c-kit expression and function. Development 1991, 113, 689–699. [Google Scholar]
  149. Schrans-Stassen, B.H.; van de Kant, H.J.; de Rooij, D.G.; van Pelt, A.M. Differential expression of c-kit in mouse undifferentiated and differentiating type A spermatogonia. Endocrinology 1999, 140, 5894–5900. [Google Scholar] [CrossRef]
  150. de Rooij, D.G.; Okabe, M.; Nishimune, Y. Arrest of spermatogonial differentiation in jsd/jsd, Sl17H/Sl17H, and cryptorchid mice. Biol. Reprod. 1999, 61, 842–847. [Google Scholar] [CrossRef] [Green Version]
  151. Costoya, J.A.; Hobbs, R.M.; Barna, M.; Cattoretti, G.; Manova, K.; Sukhwani, M.; Orwig, K.E.; Wolgemuth, D.J.; Pandolfi, P.P. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 2004, 36, 653–659. [Google Scholar] [CrossRef] [Green Version]
  152. Buaas, F.W.; Kirsh, A.L.; Sharma, M.; McLean, D.J.; Morris, J.L.; Griswold, M.D.; de Rooij, D.G.; Braun, R.E. Plzf is required in adult male germ cells for stem cell self-renewal. Nat. Genet. 2004, 36, 647–652. [Google Scholar] [CrossRef] [PubMed]
  153. Filipponi, D.; Hobbs, R.M.; Ottolenghi, S.; Rossi, P.; Jannini, E.A.; Pandolfi, P.P.; Dolci, S. Repression of kit expression by Plzf in germ cells. Mol. Cell Biol. 2007, 27, 6770–6781. [Google Scholar] [CrossRef] [Green Version]
  154. Hobbs, R.M.; Fagoonee, S.; Papa, A.; Webster, K.; Altruda, F.; Nishinakamura, R.; Chai, L.; Pandolfi, P.P. Functional antagonism between Sall4 and Plzf defines germline progenitors. Cell Stem Cell 2012, 10, 284–298. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  155. Gely-Pernot, A.; Raverdeau, M.; Teletin, M.; Vernet, N.; Feret, B.; Klopfenstein, M.; Dennefeld, C.; Davidson, I.; Benoit, G.; Mark, M.; et al. Retinoic Acid Receptors Control Spermatogonia Cell-Fate and Induce Expression of the SALL4A Transcription Factor. PLoS Genet. 2015, 11, e1005501. [Google Scholar] [CrossRef] [PubMed]
  156. Teletin, M.; Vernet, N.; Ghyselinck, N.B.; Mark, M. Roles of Retinoic Acid in Germ Cell Differentiation. Curr. Top Dev. Biol. 2017, 125, 191–225. [Google Scholar]
  157. Busada, J.T.; Chappell, V.A.; Niedenberger, B.A.; Kaye, E.P.; Keiper, B.D.; Hogarth, C.A.; Geyer, C.B. Retinoic acid regulates Kit translation during spermatogonial differentiation in the mouse. Dev. Biol. 2015, 397, 140–149. [Google Scholar] [CrossRef] [Green Version]
  158. Busada, J.T.; Geyer, C.B. The Role of Retinoic Acid (RA) in Spermatogonial Differentiation. Biol. Reprod. 2016, 94, 10. [Google Scholar] [CrossRef] [Green Version]
  159. Gely-Pernot, A.; Raverdeau, M.; Celebi, C.; Dennefeld, C.; Feret, B.; Klopfenstein, M.; Yoshida, S.; Ghyselinck, N.B.; Mark, M. Spermatogonia differentiation requires retinoic acid receptor gamma. Endocrinology 2012, 153, 438–449. [Google Scholar] [CrossRef] [Green Version]
  160. Ikami, K.; Tokue, M.; Sugimoto, R.; Noda, C.; Kobayashi, S.; Hara, K.; Yoshida, S. Hierarchical differentiation competence in response to retinoic acid ensures stem cell maintenance during mouse spermatogenesis. Development 2015, 142, 1582–1592. [Google Scholar] [CrossRef] [Green Version]
  161. Nicholls, P.K.; Harrison, C.A.; Rainczuk, K.E.; Wayne Vogl, A.; Stanton, P.G. Retinoic acid promotes Sertoli cell differentiation and antagonises activin-induced proliferation. Mol. Cell Endocrinol. 2013, 377, 33–43. [Google Scholar] [CrossRef]
  162. Huang, H.F.; Marshall, G.R. Failure of spermatid release under various vitamin A states - an indication of delayed spermiation. Biol. Reprod. 1983, 28, 1163–1172. [Google Scholar] [CrossRef] [PubMed]
  163. Chung, S.S.; Sung, W.; Wang, X.; Wolgemuth, D.J. Retinoic acid receptor alpha is required for synchronization of spermatogenic cycles and its absence results in progressive breakdown of the spermatogenic process. Dev. Dyn. 2004, 230, 754–766. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  164. Chung, S.S.W.; Wang, X.Y.; Wolgemuth, D.J. Male sterility in mice lacking retinoic acid receptor alpha involves specific abnormalities in spermiogenesis. Differentiation 2005, 73, 188–198. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  165. Chung, S.S.; Wang, X.; Wolgemuth, D.J. Expression of retinoic acid receptor alpha in the germline is essential for proper cellular association and spermiogenesis during spermatogenesis. Development 2009, 136, 2091–2100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  166. Chung, S.S.; Wang, X.; Roberts, S.S.; Griffey, S.M.; Reczek, P.R.; Wolgemuth, D.J. Oral administration of a retinoic Acid receptor antagonist reversibly inhibits spermatogenesis in mice. Endocrinology 2011, 152, 2492–2502. [Google Scholar] [CrossRef] [Green Version]
  167. Hasegawa, K.; Saga, Y. Retinoic acid signaling in Sertoli cells regulates organization of the blood-testis barrier through cyclical changes in gene expression. Development 2012, 139, 4347–4355. [Google Scholar] [CrossRef] [Green Version]
  168. Chung, S.S.; Wang, X.; Wolgemuth, D.J. Prolonged Oral Administration of a Pan-Retinoic Acid Receptor Antagonist Inhibits Spermatogenesis in Mice With a Rapid Recovery and Changes in the Expression of Influx and Efflux Transporters. Endocrinology 2016, 157, 1601–1612. [Google Scholar] [CrossRef]
  169. Hosken, D.J.; Hodgson, D.J. Why do sperm carry RNA? Relatedness, conflict, and control. Trends Ecol. Evol. 2014, 29, 451–455. [Google Scholar] [CrossRef] [Green Version]
  170. Sugimoto, R.; Nabeshima, Y.I.; Yoshida, S. Retinoic acid metabolism links the periodical differentiation of germ cells with the cycle of Sertoli cells in mouse seminiferous epithelium. Mech. Dev. 2012, 128, 610–624. [Google Scholar] [CrossRef]
  171. Teletin, M.; Vernet, N.; Yu, J.; Klopfenstein, M.; Jones, J.W.; Feret, B.; Kane, M.A.; Ghyselinck, N.B.; Mark, M. Two functionally redundant sources of retinoic acid secure spermatogonia differentiation in the seminiferous epithelium. Development 2019, 146, 1–14. [Google Scholar] [CrossRef] [Green Version]
  172. Beedle, M.T.; Stevison, F.; Zhong, G.; Topping, T.; Hogarth, C.; Isoherranen, N.; Griswold, M.D. Sources of all-trans retinal oxidation independent of the aldehyde dehydrogenase 1A isozymes exist in the postnatal testis. Biol. Reprod. 2019, 100, 547–560. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  173. Masaki, K.; Sakai, M.; Kuroki, S.; Jo, J.I.; Hoshina, K.; Fujimori, Y.; Oka, K.; Amano, T.; Yamanaka, T.; Tachibana, M.; et al. FGF2 Has Distinct Molecular Functions from GDNF in the Mouse Germline Niche. Stem Cell Rep. 2018, 10, 1782–1792. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  174. Parekh, P.A.; Garcia, T.X.; Waheeb, R.; Jain, V.; Gandhi, P.; Meistrich, M.L.; Shetty, G.; Hofmann, M.C. Undifferentiated spermatogonia regulate Cyp26b1 expression through NOTCH signaling and drive germ cell differentiation. FASEB J. 2019, 33, 8423–8435. [Google Scholar] [CrossRef] [PubMed]
  175. Hayashi, K.; Ohta, H.; Kurimoto, K.; Aramaki, S.; Saitou, M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011, 146, 519–532. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Hayashi, K.; Ogushi, S.; Kurimoto, K.; Shimamoto, S.; Ohta, H.; Saitou, M. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science 2012, 338, 971–975. [Google Scholar] [CrossRef] [Green Version]
  177. Hikabe, O.; Hamazaki, N.; Nagamatsu, G.; Obata, Y.; Hirao, Y.; Hamada, N.; Shimamoto, S.; Imamura, T.; Nakashima, K.; Saitou, M.; et al. Reconstitution in vitro of the entire cycle of the mouse female germ line. Nature 2016, 539, 299–303. [Google Scholar] [CrossRef]
  178. Zhou, Q.; Wang, M.; Yuan, Y.; Wang, X.; Fu, R.; Wan, H.; Xie, M.; Liu, M.; Guo, X.; Zheng, Y.; et al. Complete Meiosis from Embryonic Stem Cell-Derived Germ Cells In Vitro. Cell Stem Cell 2016, 18, 330–340. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Anterior-to-posterior wave of Dazl and Stra8 expression from E10.5 to E14.5 in mouse fetal gonads. Germ cells are shown in circles, with cells expressing Dazl shown in orange, and cells expressing Stra8 and Dazl shown in blue. After gonadal colonization, germ cells continue to proliferate until E13.5 [22]. In the fetal mouse testis, germ cells become enclosed by somatic cells, with testis cords formed between E12.5 to E14.0 [14,23].
Figure 1. Anterior-to-posterior wave of Dazl and Stra8 expression from E10.5 to E14.5 in mouse fetal gonads. Germ cells are shown in circles, with cells expressing Dazl shown in orange, and cells expressing Stra8 and Dazl shown in blue. After gonadal colonization, germ cells continue to proliferate until E13.5 [22]. In the fetal mouse testis, germ cells become enclosed by somatic cells, with testis cords formed between E12.5 to E14.0 [14,23].
Biomolecules 09 00775 g001
Figure 2. Diagram of germ cell development in mouse fetal gonads of both sexes. Red box: female gonad (ovary). Blue box: male gonad (testis). DAZL, STRA8, REC8, and NANOS2 are expressed in germ cells. ALDH1A1 and CYP26B1 are expressed in fetal gonads. ALDH1A2 and ALDH1A3 are expressed outside the gonads.
Figure 2. Diagram of germ cell development in mouse fetal gonads of both sexes. Red box: female gonad (ovary). Blue box: male gonad (testis). DAZL, STRA8, REC8, and NANOS2 are expressed in germ cells. ALDH1A1 and CYP26B1 are expressed in fetal gonads. ALDH1A2 and ALDH1A3 are expressed outside the gonads.
Biomolecules 09 00775 g002
Figure 3. Structure of the mouse testis comprising seminiferous tubules. In any given tubule cross-section, one observes germ cells at different steps of their development into elongated spermatids. These germ cell types are concentrically layered; undifferentiated spermatogonia lie on the basal lamina of the tubule, and germ cells move toward the tubule lumen as they differentiate [106]. Germ cell differentiation is precisely timed; hence, particular steps of development are always found together in close physical proximity. Blue line indicates the orientation of testis cross-sections. A representative tubule cross-section in stage VII–VIII, stained with hematoxylin and periodic acid-Schiff (He-PAS), is shown with grayscale version. Star: Sertoli cell nucleus. White arrowhead: type spermatogonium. Dots: preleptotene (red) spermatocytes, pachytene spermatocytes (yellow), and step 7–8 round spermatids (green). Brown area: elongated spermatids. Scale bar = 30 μm.
Figure 3. Structure of the mouse testis comprising seminiferous tubules. In any given tubule cross-section, one observes germ cells at different steps of their development into elongated spermatids. These germ cell types are concentrically layered; undifferentiated spermatogonia lie on the basal lamina of the tubule, and germ cells move toward the tubule lumen as they differentiate [106]. Germ cell differentiation is precisely timed; hence, particular steps of development are always found together in close physical proximity. Blue line indicates the orientation of testis cross-sections. A representative tubule cross-section in stage VII–VIII, stained with hematoxylin and periodic acid-Schiff (He-PAS), is shown with grayscale version. Star: Sertoli cell nucleus. White arrowhead: type spermatogonium. Dots: preleptotene (red) spermatocytes, pachytene spermatocytes (yellow), and step 7–8 round spermatids (green). Brown area: elongated spermatids. Scale bar = 30 μm.
Biomolecules 09 00775 g003
Figure 4. Multiplication of undifferentiated spermatogonia and spermatogonial differentiation. Upon division, the Asingle (As) spermatogonia can self-renew and produce two new singles or the daughter cells, Apaired (Apr) spermatogonia, remain connected by an intercellular bridge. The Apr spermatogonia subsequently divide further into chains of 4, 8, or 16 cells, called Aaligned (Aal) spermatogonia that undergo spermatogonial differentiation (purple) in response to RA. As, Apr, and Aal spermatogonia are referred to as undifferentiated spermatogonia. After the spermatogonial differentiation, Aal spermatogonia transit into A1 differentiating spermatogonia without a mitotic division [114]. Expression patterns of PLZF, RARγ, STRA8, SALL4, and KIT are indicated as solid lines.
Figure 4. Multiplication of undifferentiated spermatogonia and spermatogonial differentiation. Upon division, the Asingle (As) spermatogonia can self-renew and produce two new singles or the daughter cells, Apaired (Apr) spermatogonia, remain connected by an intercellular bridge. The Apr spermatogonia subsequently divide further into chains of 4, 8, or 16 cells, called Aaligned (Aal) spermatogonia that undergo spermatogonial differentiation (purple) in response to RA. As, Apr, and Aal spermatogonia are referred to as undifferentiated spermatogonia. After the spermatogonial differentiation, Aal spermatogonia transit into A1 differentiating spermatogonia without a mitotic division [114]. Expression patterns of PLZF, RARγ, STRA8, SALL4, and KIT are indicated as solid lines.
Biomolecules 09 00775 g004
Figure 5. Diagram of mouse spermatogenesis. Oakberg [106] identified 12 distinct cellular associations, called seminiferous stages I–XII. It takes 8.6 days for a section of seminiferous tubule, and the germ cells contained within, to cycle through all 12 stages [122]. Four turns of this seminiferous cycle are required for a germ cell to progress from undifferentiated spermatogonium to spermatozoon. As, Apr, and Aal: Asingle, Apaired, and Aaligned spermatogonia. A1–A4: A1–A4 differentiating spermatogonia. In, and B: intermediate and type B spermatogonia. Pl, L, Z, P, D, and SC2: preleptotene, leptotene, zygotene, pachytene, diplotene, and secondary spermatocytes. Steps 1–16: steps in spermatid differentiation. Purple: germ cells undergoing spermatogonial differentiation; green: meiotic initiation; brown: initiation of spermatid elongation; gray: release of elongated spermatids. Black box: population of undifferentiated spermatogonia. Gray box: the leptotene spermatocytes undergoing migration of basal to luminal compartment [123]. Dark blue: stage with high RA concentration. Light blue line: STRA8 expression in the unperturbed testis. Dashed light blue line: STRA8 expression induced by RA injection in undifferentiated spermatogonia. (After RA injection, undifferentiated Aal spermatogonia in stages II–VI precociously express STRA8 [124]).
Figure 5. Diagram of mouse spermatogenesis. Oakberg [106] identified 12 distinct cellular associations, called seminiferous stages I–XII. It takes 8.6 days for a section of seminiferous tubule, and the germ cells contained within, to cycle through all 12 stages [122]. Four turns of this seminiferous cycle are required for a germ cell to progress from undifferentiated spermatogonium to spermatozoon. As, Apr, and Aal: Asingle, Apaired, and Aaligned spermatogonia. A1–A4: A1–A4 differentiating spermatogonia. In, and B: intermediate and type B spermatogonia. Pl, L, Z, P, D, and SC2: preleptotene, leptotene, zygotene, pachytene, diplotene, and secondary spermatocytes. Steps 1–16: steps in spermatid differentiation. Purple: germ cells undergoing spermatogonial differentiation; green: meiotic initiation; brown: initiation of spermatid elongation; gray: release of elongated spermatids. Black box: population of undifferentiated spermatogonia. Gray box: the leptotene spermatocytes undergoing migration of basal to luminal compartment [123]. Dark blue: stage with high RA concentration. Light blue line: STRA8 expression in the unperturbed testis. Dashed light blue line: STRA8 expression induced by RA injection in undifferentiated spermatogonia. (After RA injection, undifferentiated Aal spermatogonia in stages II–VI precociously express STRA8 [124]).
Biomolecules 09 00775 g005

Share and Cite

MDPI and ACS Style

Endo, T.; Mikedis, M.M.; Nicholls, P.K.; Page, D.C.; de Rooij, D.G. Retinoic Acid and Germ Cell Development in the Ovary and Testis. Biomolecules 2019, 9, 775.

AMA Style

Endo T, Mikedis MM, Nicholls PK, Page DC, de Rooij DG. Retinoic Acid and Germ Cell Development in the Ovary and Testis. Biomolecules. 2019; 9(12):775.

Chicago/Turabian Style

Endo, Tsutomu, Maria M. Mikedis, Peter K. Nicholls, David C. Page, and Dirk G. de Rooij. 2019. "Retinoic Acid and Germ Cell Development in the Ovary and Testis" Biomolecules 9, no. 12: 775.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop